Most recent imaging demonstrated a 2-cm focus in the dome of her liver.
Recent CT chest was negative for cancer.
Her MELD score was 32 most recently.
A bone scan on [**2123-8-12**] demonstrated no evidence of metastatic disease and hypertrophic osteoarthropathy in the femurs and tibias, left greater than right.
Most recent CT of the abdomen on [**2123-8-5**] demonstrated no residual tumor after radiofrequency ablation site in superomedial segment 8, a 1-cm lesion concerning for early hepatocellular carcinoma, a 5-mm calculus over the lower pole of the right kidney.
PHYSICAL EXAMINATION:  Vital signs 98.4, 73, 137/86, respiratory rate 20 and 100% on room air.
Vascular: Feet were warm with 2+ pulses bilaterally.
EBL was 1400.
Urine output was 1100 cc.
Urine output was excellent.
LFTs increased postoperative day 1 with an AST of 1616, ALT of 768, alkaline phosphatase 83 and total bilirubin of 1.6 from an AST of 46, ALT of 26, alkaline phosphatase of 120 and total bilirubin 1.5.
A CT of the abdomen was done.
A duplex ultrasound was done.
Evaluation of the left hepatic vein, hepatic artery and portal vein were limited by the presence of overlying support structures and the color flow was demonstrated but the wave forms were poorly assessed.
The pathology report from the explant demonstrated hepatocellular carcinoma and gallbladder with mild, chronic cholecystitis and no malignancy identified.
A chest x-ray demonstrated right internal jugular line tip resting in the proximal SVC level.
She received packed red blood cells and fresh frozen plasma for a hematocrit of 28.8 with an INR of 1.5.
She received induction of immunosuppression of a gram of CellCept and 500 mg of Solu- Medrol.
Urine output was excellent.
Vital signs were stable.
Creatinine was stable throughout this hospital course, ranging between 1.0 and 1.4.
Blood sugars ranged from 155 to 149.
On postop day 7, her LFTs were AST of 73, ALT of 142, alkaline phosphatase 121, total bilirubin 1.2.
Stool was sent for C. difficile and subsequently negative.
Blood cultures were done and subsequently negative.
Given concern for slight increase in alkaline phosphatase on postop day 7, alkaline phosphatase was 102, in the catheterization lab by cardiology, an angiogram was performed to assess the hepatic artery.
Arterial- to-arterial connection from the SMA to the celiac artery was intact.
On [**10-19**], a transjugular liver biopsy was done with [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 44263**] needle.
A 3-mm pressure gradient was observed from the right hepatic vein to the IVC/RA.
On [**10-19**], postop day 11, AST was 34, ALT 96, alkaline phosphatase 209 with a total bilirubin of 1.0.
Urine output was excellent.
Vital signs were stable.
Hematocrit was stable at 33.8.
Prograf levels were adjusted daily based on levels.
On [**10-20**], she underwent an abdominal CT that demonstrated a normal transplant liver on CT, with normal parenchymal enhancement, patent hepatic veins and inferior vena cava, portal veins and hepatic artery.
On [**10-22**], she underwent an ERCP.
Blood cultures were negative.
Urine culture was negative.
All stool cultures that were sent on 5 different days were repeatedly negative.
Her white blood cell count was stable in the 6.1 to 7.8 range.
She remained afebrile post-ERCP and amylase postprocedure was 53 and 23.
On postop day 18, on [**10-25**], a CT of the abdomen was done to evaluate the portal and hepatic vessels.
A CTA of the chest was done to evaluate for PE confirmation, and to rule out a saddle embolus.
Coumadin was initiated at 3 mg. INR increased to 2.5 after 4 days.
The O2 saturations had been stable.
Her oxygenation was within normal limits.
On postop day 21, her AST was 16, ALT 22, alkaline phosphatase 148, total bilirubin 0.5.
A HIDA scan was done that demonstrated no evidence of bile leak.
On the duplex ultrasound of the liver, it demonstrated no abnormal intrahepatic biliary dilatation.
Vital signs continued to be stable.
Nutrition followed along and Boost supplements were provided.
White blood cell count was 3, hematocrit 26.9, AST 66, ALT 137, alkaline phosphatase 170, total bilirubin 1.4.
Blood sugars ranged between 83 and 107, and as high as 161.
She was discharged home on [**11-1**], alert and oriented, comfortable, with Percocet, on Coumadin with therapeutic INR of 2.2.
LABORATORY DATA:  Labs upon discharge: White blood cell count 3.8, hematocrit 31.4, platelet count 107, PT 17.7, PTT 32.7, INR 2.2, sodium 139, potassium 4.9, chloride 102, bicarbonate 28, BUN 16, creatinine 1.1, glucose within normal range.
AST 17, ALT 29, alkaline phosphatase 154, total bilirubin 0.4, Prograf 9.9.
[**MD Number(2) 6727**]  Dictated By:[**Name8 (MD) 4664**] MEDQUIST36 D:  [**2123-11-8**] 14:56:57 T:  [**2123-11-9**] 10:53:55 Job#:  [**Job Number 59205**]
